Publication | Closed Access

Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice

Surgical OncologyFolfox4 RegimenPancreatic CancerGastrointestinal OncologyMedicinePharmacologyPathologyClinical PracticeOncologyRadiation OncologyCancer ResearchSecond-line Chemotherapy